Erasca, Inc. ERAS
14.25
(0.27)
(1.86%)
as of 25 Sep
- Market cap
- $5.1B
- P/E
- 0.0×
Follow ERAS
| Dec '17 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|---|
Current Ratio |
— | 18.59 | 8.77 | 16.02 | 9.13 | 12.26 | 9.84 | 10.04 |
Net Debt/EBITDA |
— | 3.60 | 1.09 | 3.34 | 1.77 | 2.16 | 1.61 | 1.93 |
Debt/Assets |
0.00% | 6.65% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Debt/Equity |
— | 0.07 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Asset Turnover |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Operating CF/Net income |
— | 0.86 | 0.32 | 0.65 | 0.43 | 0.81 | 0.68 | 0.77 |
Capex/Depreciation |
— | 0.00 | (77.08) | (20.15) | (10.05) | 6.76 | 3.90 | 4.86 |
Interest Coverage |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| — | 18.87% | 159.36% | (71.68%) | (55.92%) | (34.33%) | (43.68%) | (33.27%) | |
| — | (43.38%) | (112.74%) | (39.21%) | (47.78%) | (27.48%) | (36.01%) | (27.72%) | |
ROIC |
— | 0.00% | 0.00% | (185.60%) | 0.00% | (2,039.97%) | (89.66%) | (179.37%) |
Return on Tangible Assets |
— | (22.84%) | (93.99%) | (29.96%) | (57.73%) | (39.46%) | (55.04%) | (45.95%) |
Research and Development Expense of Revenue |
— | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
— | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
— | — | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Free Cash Flow per Share |
— | (0.09) | (3.39) | (1.49) | (0.98) | (0.82) | (0.56) | (0.37) |
Cash per Share |
— | 0.42 | 5.64 | 6.25 | 3.57 | 2.08 | 1.28 | 0.97 |
Shareholders Equity per Share |
— | 0.42 | (5.42) | 6.89 | 3.38 | 2.11 | 1.81 | 1.15 |
Interest Debt per Share |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
— | 0.42 | (5.42) | 6.89 | 3.38 | 2.11 | 1.81 | 1.15 |
Free Cash Flow |
— | (10.38) | (71.38) | (98.48) | (119.81) | (122.99) | (131.98) | (105.08) |
Working Capital |
— | 48.37 | 106.31 | 393.79 | 395.81 | 294.52 | 277.40 | 257.73 |
Capital Expenditures |
— | (0.60) | (38.69) | (18.88) | (16.55) | (21.77) | (22.56) | (9.63) |
Net Current Asset Value |
— | 45.41 | (118.82) | 375.13 | 341.44 | 242.07 | 229.77 | 215.26 |
| Other line items | ||||||||
Quick Ratio |
— | 18.32 | 8.68 | 15.81 | 8.95 | 11.94 | 9.50 | 9.68 |
Depreciation/Fixed assets |
— | 0.07 | 0.27 | 0.06 | 0.07 | (0.14) | (0.35) | (0.15) |
Cash ROIC |
— | (14.17%) | (732.10%) | (10.97%) | (15.11%) | (19.64%) | (17.42%) | (18.09%) |
Accounts Payable Turnover |
— | 0.27 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Inventory Turnover |
— | 0.00 | 0.00 | 0.00 | 0.00 | — | — | — |
Average Days of Payables |
— | 1,626.02 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Days of Inventory on Hand |
— | 0.00 | 0.00 | 0.00 | 0.00 | — | — | — |
Revenue per Share |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Operating CF per Share |
— | (0.09) | (1.55) | (1.20) | (0.85) | (0.67) | (0.47) | (0.34) |
Capex per Share |
— | 0.00 | (1.84) | (0.28) | (0.14) | (0.14) | (0.10) | (0.03) |
Average Payables |
— | 1.13 | 1.13 | 2.78 | 13.86 | 12.52 | 1.23 | 0.72 |
Average Assets |
— | 27.76 | 90.17 | 313.12 | 508.16 | 455.10 | 448.91 | 449.34 |
Average Common Equity |
— | (63.79) | (63.79) | 171.27 | 434.19 | 364.27 | 370.09 | 374.33 |
Capex to Sales |
— | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Profit Margin |
— | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Columns are period end dates